US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.93

+0.36781.17%

Volume:3K

Turnover:104.49K

Market Cap:51.84M

PE:- -

High:32.23

Open:31.63

Low:31.63

Close:31.56

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.51

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod

Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale

Simply Wall St.

Lifestance Health Q2 Call Highlights Profitable Growth

Major Insider Move at Lifestance Health Group Shakes Up Investor Watchlists

LifeStance Health Director Teresa DeLuca Sells 20,441 Shares Worth $249,991.43

Steris PLC Stock Outperforms Competitors Despite Losses on the Day

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

MT Newswires Live

Major Insider Move Shakes Up Lifestance Health Group

10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million

Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan

Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors

LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20

10x Genomics is Maintained at Overweight by Stephens & Co.

10x Genomics (TXG) Gets a Buy from Stephens

Thermo Fisher Completes Sale of Microbiology Business to Astorg for $1.08 Billion

Thermo Fisher Scientific Completes Sale of Its Microbiology Business to Astorg

THOMSON REUTERS

Danaher (DHR) Could Be 9% Undervalued Following Its CEO Transition News

Simply Wall St.

10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50

THOMSON REUTERS

Achieve Life Sciences Q2 Loss Widens on Warrant Liabilities

908 Devices Q2 Revenue Beats on Increased VipIR Sales

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/FMED/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":31.925,"timestamp":1788377846142,"preClose":31.5572,"halted":0,"volume":3277,"delay":0,"changeRate":0.01165502642820019,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Trading","change":0.3678,"latestTime":"09-02 15:43:18 EDT","open":31.63,"high":32.23,"low":31.63,"amount":104485.483561,"amplitude":0.019013,"askPrice":32,"askSize":500,"bidPrice":31.93,"bidSize":571,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":31.5572,"sharesOutstanding":2323806,"nav":31.741048,"aum":51541304.188688,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.54,"preClose":31.5572,"latestTime":"19:30 EDT","volume":9,"amount":284.9004,"timestamp":1788305405892,"change":-0.0172,"changeRate":-0.000545,"amplitude":0},"volumeRatio":0.506266,"impliedVol":0.0806,"impliedVolPercentile":0.2543},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.506266,"shares":1623806,"dividePrice":0,"high":32.23,"amplitude":0.019013,"preClose":31.5572,"low":31.63,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":31.925,"committee":0.066293,"eps":0,"divideRate":0,"volume":3277,"delay":0,"ttmEps":0,"open":31.63,"prevYearClose":27.05,"prevWeekClose":31.6372,"prevMonthClose":31.775,"prevQuarterClose":28.525,"fiveDayClose":32.4944,"twentyDayClose":28.8396,"sixtyDayClose":24.385},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660948803","title":"Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2660948803","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660948803?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:08","pubTimestamp":1786954080,"startTime":"0","endTime":"0","summary":"Shares in Argenx rose after the European pharmaceutical company reported positive results from the phase 3 trial of Efgartigimod for the treatment of autoimmune myositis.In early morning trading, shar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4505","LU1983260115.SGD","IBB","LU2324357040.USD","IE0034235188.USD","IE00BJT1NW94.SGD","BK4585","IE0002141913.USD","BK4139","ARGX","TBXU","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4588","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU0823416689.USD","FMED","IE00B4R5TH58.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660828109","title":"Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2660828109","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660828109?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:35","pubTimestamp":1786926913,"startTime":"0","endTime":"0","summary":"Thermo Fisher Scientific stock has delivered a 20.7% gain over the past year, and the latest checks suggest it now sits close to its estimated intrinsic value rather than looking clearly cheap or clearly expensive.\n\nThermo Fisher Scientific is up 20.7% over the past 12 months, which puts more focus on whether current buyers are paying a fair price for the cash flows that the business may generate.\nThe recent sale of the microbiology business and ongoing work in proteomics and precision...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/97023-main-header/1756189961534","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/97023-main-header/1756189961534"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-tmo-stock-may-be-8-below-fair-value-on-microbi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-tmo-stock-may-be-8-below-fair-value-on-microbi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","IE00BJT1NW94.SGD","SPHQ","LU0070302665.USD","LU1815333072.USD","BK4534","IE00BQXX3F31.USD","LU2360108059.USD","IE0034235188.USD","LU0310800379.SGD","LU1988902786.USD","LU2468319806.SGD","LU0316494557.USD","LU2125910336.SGD","LU0345770308.USD","IE00B2B36J28.USD","LU0957791311.USD","LU1712237335.SGD","IE00B1BXHZ80.USD","IE00B19Z9505.USD","LU2041044095.USD","LU2063271972.USD","LU1854103824.USD","LU0320765489.SGD","LU2720916845.USD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","TMED","LU0122379950.USD","LU0061474960.USD","LU1670628061.USD","FMED","BK4533","BK4566","LU2092937221.SGD","LU0114720955.EUR","HRTS","BK4581","LU0640476718.USD","LU1153585028.USD","IE00B19Z8X17.USD","LU1923622291.USD","DCF","LU0011850046.USD","LU1720051017.SGD","TMO","LU2764263039.SGD","LU2764262908.HKD","LU2264538146.SGD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659794001","title":"Lifestance Health Q2 Call Highlights Profitable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659794001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659794001?lang=en_us&edition=fundamental","pubTime":"2026-08-16 08:15","pubTimestamp":1786839326,"startTime":"0","endTime":"0","summary":"Lifestance Health Group, Inc. (($LFST)) has held its Q2 earnings call. Read on for the main highlights of the call. Lifestance Health Group’s lates...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lifestance-health-q2-call-highlights-profitable-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lifestance-health-q2-call-highlights-profitable-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","VGFPF","FEBU","BK4196","PMDE","GXDW","RGLO","VOTE","JOYT","DECU","LFST","BK4539","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659272581","title":"Major Insider Move at Lifestance Health Group Shakes Up Investor Watchlists","url":"https://stock-news.laohu8.com/highlight/detail?id=2659272581","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659272581?lang=en_us&edition=fundamental","pubTime":"2026-08-15 10:12","pubTimestamp":1786759945,"startTime":"0","endTime":"0","summary":"New insider activity at Lifestance Health Group ( ($LFST) ) has taken place on August 14, 2026. Director Teresa DeLuca of Lifestance Health Group h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-lifestance-health-group-shakes-up-investor-watchlists-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-lifestance-health-group-shakes-up-investor-watchlists-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFST","BK4196","BK4535","FMED","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659241131","title":"LifeStance Health Director Teresa DeLuca Sells 20,441 Shares Worth $249,991.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2659241131","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659241131?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:51","pubTimestamp":1786744271,"startTime":"0","endTime":"0","summary":"LifeStance Health director Teresa DeLuca sells 20,441 shares worth $249,991.43LifeStance Health director Teresa DeLuca sold 20,441 common shares on Aug. 13, 2026 at USD 12.23.DeLuca held 104,593 share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4ZnLZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LifeStance Health Director Teresa DeLuca Sells 20,441 Shares Worth $249,991.43","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","FMED","LFST","BK4539","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659217491","title":"Steris PLC Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2659217491","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659217491?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:06","pubTimestamp":1786741560,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  slid 1.18% to $233.28 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.17% to 7,785.76 and Dow Jones Industrial Average  falling 0.20% to 53,732.41.This was the stock's fourth consecutive day of losses.Steris PLC closed 13.42% short of its 52-week high of $269.44, which the company reached on January 16th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Thermo Fisher Scientific Inc.  fell 1.28% to $588.29, Danaher Corp.  fell 0.71% to $202.45, and Becton Dickinson & Co.  rose 0.79% to $183.40.Trading volume  remained 231,699 below its 50-day average volume of 811,394.Data source: Dow Jones Market Data, FactSet. Data compiled August 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHI","GNMX","IE00BKVL7J92.USD","HRTS","LU1720051108.HKD","LU1571399168.USD","LU0957791311.USD","LU1804176565.USD","LU2543165471.USD","LU0208291251.USD","LU1023059063.AUD","LU1061106388.HKD","LU2023250504.SGD","LU0310800379.SGD","LU1917777945.USD","LU1923621640.USD","LU0006061336.USD","LU1623119135.USD","LU0097036916.USD","FMED","GB00BDT5M118.USD","LU1064131342.USD","TMED","LU2360108059.USD","LU0096362180.USD","TMO","IE00BJJMRZ35.SGD","LU1551013425.SGD","LU0943347566.SGD","IE0004445239.USD","LU0070302665.USD","LU0477156797.USD","IE00BQXX3F31.USD","LU2211814178.USD","LU0057025933.USD","LU2468319806.SGD","LU1854103824.USD","LU0114720955.EUR","LU2125910179.SGD","BDX","DHR","LU0345770993.USD","STE","LU2089984988.USD","LU0320765489.SGD","LU0985320562.USD","LU2125910336.SGD","LU1201861165.SGD","LU1057294990.SGD","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140268","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140268","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140268?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:08","pubTimestamp":1786720082,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.35% to 1,962.14 on the S&P Europe Select ADR Index, which is up 0.17% for the we","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LNOK","LU2324357040.USD","BDRX","EPV","NOK","PXE","WTIU","DBE","SHEL","NCNA","USE","VDE","BPH","DBC","AUTL","ARGX","DBVT","IEUR","IBB","CLLS","EQNR","AFG","IEO","FMED","BK4547","DRIP","E","DRLL","LU0889565916.HKD","TRIB","IE0009355771.USD","XES","ERX","BK4107","IXC","SHEH","TBXU","BCYC","GUSH","AKTX","BP","BK4201","FTXN","LU1983260115.SGD","SQNS","PXJ","LU0320765646.SGD","DIG","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659948871","title":"Major Insider Move Shakes Up Lifestance Health Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2659948871","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659948871?lang=en_us&edition=fundamental","pubTime":"2026-08-14 10:03","pubTimestamp":1786673036,"startTime":"0","endTime":"0","summary":"New insider activity at Lifestance Health Group ( ($LFST) ) has taken place on August 13, 2026. Director Kenneth Burdick has executed a major sale ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-lifestance-health-group-insider-trading-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-lifestance-health-group-insider-trading-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FMED","LFST","BK4196","BK4539","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659208162","title":"10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659208162","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659208162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:13","pubTimestamp":1786651992,"startTime":"0","endTime":"0","summary":"10x Genomics director John R. Stuelpnagel sells 20,000 shares worth $1.15 million10x Genomics director John R. Stuelpnagel sold 20,000 Class A common shares on Aug. 11, 2026.Sales priced at USD 57.58 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLZd8PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4121","LU1861558580.USD","BK4585","BK4548","FMED","LU1861559042.SGD","ARKG","TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164067","title":"Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164067","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164067?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651375,"startTime":"0","endTime":"0","summary":"Thermo Fisher EVP Michael D. Shafer disposes of 25,500 common shares worth $15.3 million under 10b5-1 planThermo Fisher Executive Vice President Michael D. Shafer sold 25,500 shares on Aug. 11 at USD ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2cbkgB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2211815571.USD","LU0234572021.USD","LU0345770308.USD","GNMX","LU1633808545.USD","LU2125909759.SGD","LU1803068623.USD","LU1923622291.USD","LU1988902786.USD","LU0320765489.SGD","LU0557290698.USD","LU0342679015.USD","LU2298321311.HKD","TMED","LU1720051017.SGD","IE00B19Z8W00.USD","LU2041044095.USD","IE00BQXX3C00.GBP","LU0823416689.USD","IE00BQXX3D17.EUR","LU0266013472.USD","LU1057294990.SGD","LU2089984988.USD","LU2125909247.SGD","LU2764263203.CNY","IE00BJT1NW94.SGD","BK4548","LU1791710582.SGD","BK4588","LU2063271972.USD","TMO","BK4585","LU1670628061.USD","LU0096362180.USD","LU1983299246.USD","FMED","LU0029864427.USD","LU1267930573.SGD","LU0122379950.USD","LU0310800379.SGD","LU0708994859.HKD","IE00BKPKM429.USD","LU2764263039.SGD","LU2357305700.SGD","HRTS","BK4533","IE00B19Z9505.USD","LU0432979614.USD","LU2125909916.SGD","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659093166","title":"Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659093166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659093166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:31","pubTimestamp":1786638686,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. The new argenx study focuses on empasiprubart in adults with multifocal motor n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","ARGX","LU0823416689.USD","BK4588","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","TBXU","LU0109394709.USD","BK4211","IE0009355771.USD","IE0034235188.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","IE00BJT1NW94.SGD","BK4505","IE00B2B36J28.USD","IE0002141913.USD","LU0320765992.SGD","BK4139","FMED","IBB","LU1983260115.SGD","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188032","title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188032","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188032?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:00","pubTimestamp":1786568426,"startTime":"0","endTime":"0","summary":"LifeStance COO Lisa K. Miller disposes of 47,912 common shares worth $519,245.20LifeStance Health COO Lisa K. Miller sold 47,912 common shares on Aug. 10 at USD 10.85.Direct holding fell to 281,289 sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL98VmhP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LFST","BK4535","BK4196","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659838901","title":"10x Genomics is Maintained at Overweight by Stephens & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659838901","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659838901?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:31","pubTimestamp":1786552260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TXG/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ARKG","LU1861558580.USD","BK4548","TXG","BK4588","LU1861559042.SGD","BK4121","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908472","title":"10x Genomics (TXG) Gets a Buy from Stephens","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908472?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:36","pubTimestamp":1786541791,"startTime":"0","endTime":"0","summary":"Stephens analyst reiterated a Buy rating on 10x Genomics today and set a price target of $65.00. In addition to Stephens, 10x Genomics also receive...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/10x-genomics-txg-gets-a-buy-from-stephens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/10x-genomics-txg-gets-a-buy-from-stephens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4588","LU1861559042.SGD","ARKG","BK4548","LU1861558580.USD","TXG","BK4585","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972674","title":"Thermo Fisher Completes Sale of Microbiology Business to Astorg for $1.08 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972674","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972674?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:03","pubTimestamp":1786536209,"startTime":"0","endTime":"0","summary":"Thermo Fisher completes sale of microbiology business to Astorg for $1.08 billionThermo Fisher completed the sale of its microbiology business to private equity firm Astorg for about $1.075 billion.Co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL5b7x1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU1815333072.USD","LU1923622291.USD","LU0432979614.USD","LU1623119135.USD","BK4581","GB00BDT5M118.USD","LU2468319806.SGD","LU2720916845.USD","LU0011850046.USD","IE0034235188.USD","LU0234572021.USD","LU0096362180.USD","IE00BQXX3D17.EUR","LU0128525929.USD","LU2764262908.HKD","LU0316494557.USD","LU1712237335.SGD","HRTS","LU1057294990.SGD","LU2063271972.USD","LU1854103824.USD","LU0266013472.USD","LU1720051017.SGD","TMO","LU0528227936.USD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU2125909916.SGD","LU1280957306.USD","LU2112291526.USD","LU0882574055.USD","LU2764263039.SGD","IE0009355771.USD","FMED","LU1670628061.USD","LU2125910336.SGD","LU2433249047.HKD","LU0345770993.USD","TMED","LU2125910179.SGD","GNMX","LU0708994859.HKD","LU1267930573.SGD","LU0114720955.EUR","LU1791710400.SGD","BK4548","LU1988902786.USD","BK4566","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658594972","title":"Thermo Fisher Scientific Completes Sale of Its Microbiology Business to Astorg","url":"https://stock-news.laohu8.com/highlight/detail?id=2658594972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658594972?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA50LBGD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU0122379950.USD","LU2764263039.SGD","HRTS","LU0096362180.USD","LU0011850046.USD","LU0345770308.USD","LU0234572021.USD","LU2298321311.HKD","IE00B19Z8W00.USD","BK4121","GB00BDT5M118.USD","LU2092937221.SGD","TMO","LU1712237335.SGD","LU1720051108.HKD","LU1988902786.USD","GNMX","IE00B4R5TH58.HKD","LU1854104046.USD","LU2125909916.SGD","BK4588","IE00B2B36J28.USD","LU0061474960.USD","IE00BFTCPJ56.SGD","LU2125910336.SGD","LU0708994859.HKD","LU0208291251.USD","LU2357305700.SGD","LU2433249047.HKD","IE00B19Z8X17.USD","LU0432979614.USD","LU1267930573.SGD","LU1023059063.AUD","IE0034235188.USD","LU1720051017.SGD","LU2764262908.HKD","IE00BJT1NW94.SGD","TMED","IE00BQXX3F31.USD","LU0316494557.USD","LU1057294990.SGD","LU1280957306.USD","BK4533","LU0882574055.USD","LU1923621640.USD","BK4566","FMED","BK4534","LU2211814178.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658973600","title":"Danaher (DHR) Could Be 9% Undervalued Following Its CEO Transition News","url":"https://stock-news.laohu8.com/highlight/detail?id=2658973600","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658973600?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:34","pubTimestamp":1786523643,"startTime":"0","endTime":"0","summary":"Danaher (DHR) is back in focus after announcing that Julie Sawyer Montgomery will become CEO and President on October 1, 2026, with outgoing CEO Rainer Blair staying on temporarily as senior advisor.\nSee our latest analysis for Danaher.\nAgainst the leadership news backdrop, Danaher's share price has risen over the past week and quarter, with a 7 day share price return of 6.5% and a 90 day share price return of 25.0%. However, the year to date share price return is down 10.0% and the 5 year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/265621-main-header/1756203226349","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/265621-main-header/1756203226349"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danaher-dhr-could-be-9-undervalued-following-its-ceo-transit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danaher-dhr-could-be-9-undervalued-following-its-ceo-transit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0107464264.USD","LU2106854487.HKD","LU0187121727.USD","LU0312595415.SGD","SG9999013999.USD","IE00BZ1G4Q59.USD","LU1791710582.SGD","BK4504","LU0122379950.USD","DHR.AU","LU1791710400.SGD","LU2023250504.SGD","LU0689472784.USD","LU0289739343.SGD","BK4121","IE000M9KFDE8.USD","LU1917777945.USD","FMED","LU0320765059.SGD","LU1551013342.USD","LU2063271972.USD","SG9999001176.USD","LU0175139822.USD","LU2112291526.USD","LU1923622614.USD","LU2125909247.SGD","LU1974910355.USD","SG9999004303.SGD","LU0289960550.SGD","LU2125909593.SGD","LU0097036916.USD","LU0390134368.USD","IE0004445239.USD","SGXZ57979304.SGD","LU1804176565.USD","BK4588","DHR","LU0114720955.EUR","LU2125910336.SGD","LU2265009873.SGD","LU1061106388.HKD","SG9999001176.SGD","BK4533","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU0511384066.AUD","LU0882574055.USD","IE00BQXX3C00.GBP","BK4581","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658923857","title":"10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2658923857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658923857?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:57","pubTimestamp":1786507046,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44903W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4588","BK4585","FMED","BK4121","TXG","ARKG","LU1861559042.SGD","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658791868","title":"Achieve Life Sciences Q2 Loss Widens on Warrant Liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658791868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658791868?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:39","pubTimestamp":1786451965,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences Q2 loss widens on warrant liabilitiesOverviewUS specialty pharma firm's Q2 net loss and loss per share missed analyst expectationsQ2 net loss includes $48.7 mln non-cash charge f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","SCYX","LU1815333072.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2264538146.SGD","LBRX","GNMX","BK4121","LU1854104046.USD","LU2125909247.SGD","LU0342679015.USD","LU0208291251.USD","LU1633808545.USD","LU0823416689.USD","LU1670628061.USD","LU2468319806.SGD","LU1803068623.USD","LU0640476718.USD","BK4585","FMED","LU2041044095.USD","LU0096362180.USD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","LU0528227936.USD","LU2764262908.HKD","LU1983299246.USD","LU1153585028.USD","TMED","LU1712237335.SGD","BK4548","HRTS","LU0882574055.USD","TMO","LU1923621640.USD","LU1623119135.USD","LU0957791311.USD","LU0234572021.USD","LU2543165471.USD","LU1057294990.SGD","ACHV","LU0122379950.USD","IE00B19Z8W00.USD","LU2764263039.SGD","IE00B1BXHZ80.USD","LU1720051108.HKD","LU2063271972.USD","IE0002141913.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992905","title":"908 Devices Q2 Revenue Beats on Increased VipIR Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992905","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992905?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:16","pubTimestamp":1786447007,"startTime":"0","endTime":"0","summary":"908 Devices Q2 revenue beats on increased VipIR salesOverviewU.S. handheld chemical analysis tool maker's Q2 revenue grew 23%, beating analyst expectationsNet loss for Q2 widened, missing analyst esti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","MASS","LU0882574055.USD","IE00B19Z8W00.USD","LU0011850046.USD","LU0096362180.USD","IE0002141913.USD","LU0345770993.USD","LU0320765489.SGD","LU1670627923.USD","BK4548","LU0432979614.USD","LU1854104046.USD","IE00BJT1NW94.SGD","LU2764262908.HKD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU0208291251.USD","IE0034235188.USD","LU1923621640.USD","LU0345770308.USD","TMED","BK4535","IE00BQXX3C00.GBP","LU2468319806.SGD","MLAB","LU1280957306.USD","IE00B1BXHZ80.USD","LU1061106388.HKD","GNMX","LU1983299246.USD","LU2720916845.USD","LU0234572021.USD","LU0316494557.USD","FMED","LU1064131342.USD","LU1548497426.USD","LU2125909759.SGD","LU2298321311.HKD","LU2764263039.SGD","TMO","LU0528227936.USD","BK4121","LU2211814178.USD","LU0061474960.USD","IE00BQXX3F31.USD","LU2125910179.SGD","LU2433249047.HKD","LU0557290698.USD","HRTS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}